A Win For Acurx Pharmaceuticals, Inc.

Mon, Mar 09, 2026 at 07:26 PM

Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ) rocketted at $1.96, a gain of 45.9%. On Mon, Mar 09, 2026, ACXP:NASDAQ hit a New 2-Week High of $1.96. The stock appeared on our News Catalysts scanner on Mon, Mar 09, 2026 at 09:56 AM in the 'BIOTECH' category. From Mon, Feb 23, 2026, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Wed, Oct 08, 2025 at $8.34 with a volume of 24M+.

About Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ)

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health...

Top 10 Gainers:

Garden Stage Limited (GSIW:NASDAQ), 248.11%
Autozi Internet Technology (Global) Ltd. (AZI:NASDAQ), 146.4%
AN2 Therapeutics, Inc. (ANTX:NASDAQ), 84.21%
Davis Commodities Limited (DTCK:NASDAQ), 74.13%
POMDOCTOR LIMITED (POM:NASDAQ), 74.07%
Xenon Pharmaceuticals Inc. (XENE:NASDAQ), 49.64%
CAMP4 THERAPEUTICS CORPORATION (CAMP:NASDAQ), 49.4%
XCF Global Inc. (SAFX:NASDAQ), 46.2%
Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 45.9%
Hims & Hers Health, Inc. (HIMS:NYSE), 40.79%